Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (47)	11/3/1998 3:15:00 PM
From: Richard Huth	Respond to of 1386

Ariella, as always you have excellent arguments on your side (I means this seriously). But I agree with David that Mgt could do a little bit better in telling the story. Having a defense plan might be a suitable answer, but it has nothing to to with shareholder value. And I see this as the #1 defense for a company. I have presented PARS to some European analysts, and they have problems to understand what makes PARS a real good investment. It is like advertising. The company has to look good on the first view, not on the third. As mentioned before, IMNX is telling a good story - on the first view. This makes it easy to interest investors for IMNX. Not so with PARS. When recommending PARS to investors I have to sell it. People are not coming and asking me to buy it. This does not sound academic, and I would not own PARS if I would not see the potential behind. But David is right when he is calling for a different PR. Ariella, if you defend Mgt. in saying they should not become just another high-fly hipe balloon as many other biotechs, I absolutely agree with you (I tried to calm down short term hopes in my posts more than once). But this cannot mean that PARS should not concentrate in selling good news the best way - and as far as I understood it, that is what David is asking for. At actual prices PARS is a goo buying opportunity - and this is something I really do not like. I am not at all satisfied with the development of the stock. And David is right bringing this subject into discussion. Hope is a good thing, but I would prefer seeing a good valuation today, and not - hopefully - in six month. I am not looking for another good buying opportunity, as I have all the shares I wanted to own. Richard

To: Ariella who wrote (47)	11/3/1998 3:48:00 PM
From: David Israel-Rosen	Read Replies (3) \| Respond to of 1386

DEAR ARIELLA: 1) You starting to sound like a C. Leader for Management. The reality is that Brokers do recommend stock below $5 (I am aware of the policies of WS Firms) 2) Three Press Releases would have the practice of any major COMPANY on WS. Check for yourself it is BASIC 3) MGT IS DEFENSIVE TO A FAULT. 4) I INTEND TO MAKE MGT RESPONSIVE TO SHARE HOLDERS. THERE IS A HUGE GAP BETWEEN INFORMING THE MARKET AND HYPING THE STOCK. 5) INVESTORS LIKE MYSELF GIVE THE COMPANY A D- FOR THE WAY THEY PROMOTE THE STOCK. 6) I HAVE FULL INTENTION OF CREATING URGENCY ON PART OF MGT TO PUSH THE STOCK. NOW !!! I EXPRESS MY LEVEL OF DISATIFACTION WITH THE CFO OF PARS 7) I HOPE THAT OTHER MEMBERS OF THIS TREAD JOIN ME !!! BEST REGARDS david